Literature DB >> 22322272

Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way.

Harrys A Torres, Javier A Adachi, Lillian R Roach, Kathleen M Smith, Parag S Mahale, Marta Davila, Issam I Raad.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22322272      PMCID: PMC6276933          DOI: 10.1093/cid/cir930

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

2.  A new era of hepatitis C therapy begins.

Authors:  Donald M Jensen
Journal:  N Engl J Med       Date:  2011-03-31       Impact factor: 91.245

3.  Effect of previous interferon treatment on outcome after curative treatment for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Hirokazu Miyatake; Yoshiyuki Kobayashi; Yoshiaki Iwasaki; Shin-Ichiro Nakamura; Hideki Ohnishi; Kenji Kuwaki; Junichi Toshimori; Hiroaki Hagihara; Kazuhiro Nouso; Kazuhide Yamamoto
Journal:  Dig Dis Sci       Date:  2011-10-12       Impact factor: 3.199

4.  The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies - a multicenter prospective trial.

Authors:  Jee-Fu Huang; Ming-Lung Yu; Chung-Feng Huang; Chang-Fu Chiu; Chia-Yen Dai; Ching-I Huang; Ming-Lun Yeh; Jeng-Fu Yang; Ming-Yen Hsieh; Nai-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Liang-Yen Wang; Wan-Long Chuang
Journal:  J Hepatol       Date:  2010-09-07       Impact factor: 25.083

5.  The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.

Authors:  A Hatzakis; S Wait; J Bruix; M Buti; M Carballo; M Cavaleri; M Colombo; E Delarocque-Astagneau; G Dusheiko; G Esmat; R Esteban; D Goldberg; C Gore; A S F Lok; M Manns; P Marcellin; G Papatheodoridis; A Peterle; D Prati; N Piorkowsky; M Rizzetto; F Roudot-Thoraval; V Soriano; H C Thomas; M Thursz; D Valla; P van Damme; I K Veldhuijzen; H Wedemeyer; L Wiessing; A R Zanetti; H L A Janssen
Journal:  J Viral Hepat       Date:  2011-09       Impact factor: 3.728

6.  Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Authors:  Carlos A Ramos; Rima M Saliba; Leandro de Pádua; Ola Khorshid; Elizabeth J Shpall; Sergio Giralt; Poliana A Patah; Chitra M Hosing; Uday R Popat; Gabriela Rondon; Issa F Khouri; Yago L Nieto; Richard E Champlin; Marcos de Lima
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

7.  Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas.

Authors:  Luca Arcaini; Michele Merli; Francesco Passamonti; Raffaele Bruno; Ercole Brusamolino; Paolo Sacchi; Sara Rattotti; Ester Orlandi; Elisa Rumi; Virginia Ferretti; Silvia Rizzi; Erika Meli; Cristiana Pascutto; Marco Paulli; Mario Lazzarino
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

8.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

9.  Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus.

Authors:  S Vento; F Cainelli; F Mirandola; L Cosco; G Di Perri; M Solbiati; T Ferraro; E Concia
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

  9 in total
  4 in total

Review 1.  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors:  Harrys A Torres; Marta Davila
Journal:  Nat Rev Clin Oncol       Date:  2012-01-24       Impact factor: 66.675

Review 2.  Challenges in managing hepatitis C virus infection in cancer patients.

Authors:  Roy A Borchardt; Harrys A Torres
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

4.  Association Between Hepatitis C Virus and Head and Neck Cancers.

Authors:  Parag Mahale; Erich M Sturgis; David J Tweardy; Ella J Ariza-Heredia; Harrys A Torres
Journal:  J Natl Cancer Inst       Date:  2016-04-13       Impact factor: 13.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.